Brief: Silence Therapeutics Announces Positive Results From Ongoing Sanreco Phase 1 Study

Silence Therapeutics

27/06/2024 12:38

June 27 (Reuters) - Silence Therapeutics PLC  SLNCF.PK :
    * SILENCE THERAPEUTICS ANNOUNCES POSITIVE RESULTS FROM
ONGOING
SANRECO PHASE 1 STUDY OF DIVESIRAN IN POLYCYTHEMIA VERA PATIENTS
    * SILENCE THERAPEUTICS: DIVESIRAN ELIMINATED NEED FOR
PHLEBOTOMY
IN ALL WELL-CONTROLLED PATIENTS FOLLOWING INFREQUENT DOSING
    * SILENCE THERAPEUTICS PLC: DIVESIRAN WAS WELL TOLERATED

Source text for Eikon:  ID:nBw6gWR1pa 
Further company coverage:  SLNCF.PK 

 ((Reuters.Briefs@thomsonreuters.com;))